NCT03508635View on ClinicalTrials.gov

CORT125134 Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD)

PHASE1CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Healthy
Interventions
DRUG

CORT125134

Oral capsules

DRUG

Matching Placebo of CORT125134

Placebo

DRUG

Mifepristone

Active comparator

DRUG

Prednisone

Challenge agent

DRUG

Glucose

Trial Locations (1)

NG11 6JS

Quotient Clinical, Nottingham

Sponsors
All Listed Sponsors
lead

Corcept Therapeutics

INDUSTRY